Research Paper Volume 11, Issue 15 pp 5463—5482
Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma
Figure 8. Survival analysis of glioma based on CD155 expression. Higher CD155 expression is associated with worse overall survival (OS) in patients with glioma (A–C) and GBM (D–F) based on data from Rembrandt dataset, TCGA dataset, and the follow-up data from 56 glioma samples from Xiangya Hospital.